Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2020-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) filed by HLB. It details the agenda for an upcoming Annual General Meeting (AGM), including the election of directors, appointment of auditors, and changes to business purposes. This document serves as the official proxy statement and notice sent to shareholders to inform them of the meeting and request their votes, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2020-03-13 Korean
[기재정정]의결권대리행사권유참고서류
AGM Information Classification · 98% confidence The document is a '정정신고(보고)' (Correction Report) for a '참고서류' (Reference Document) related to a shareholder meeting. It contains detailed information regarding the agenda for the 35th Annual General Meeting (AGM) of HLB Co., Ltd., including board member nominations, changes to the articles of incorporation, and proxy solicitation details. Since this document provides the materials and information necessary for shareholders to vote at the upcoming AGM, it is classified as Proxy Solicitation & Information Statement.
2020-03-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for HLB Co., Ltd. It details the meeting date, location, agenda items (approval of financial statements, election of directors, etc.), and voting procedures. This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming AGM and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-13 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date'. It explains the company's inability to avoid this date due to audit report timelines. Since this is a regulatory disclosure regarding meeting logistics and compliance with corporate governance reporting requirements rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2020-03-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the major shareholder (Jin Yang-gon) of HLB Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-03-10 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 95% confidence The document is a formal notice regarding the suspension of share registration (shareholder register closure) for HLB, specifically citing the purpose as determining shareholders for a capital increase (rights offering). This type of regulatory disclosure regarding corporate actions and shareholder record dates is standard for regulatory filings in the Korean market (KRX). Since it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-03-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.